JFNNX Holdings Information

JFNNX is a mutual fund with a total of 98 individual holdings. The top holdings are Eli Lilly and Company stock at 9.05%, Johnson & Johnson at 7.48%, AbbVie at 4.63%, UnitedHealth Group at 4.33%, and AstraZeneca at 3.50%.

Total Holdings

Top 10 Percentage

42.22%

Asset Class

Equity

Fund Category

Health

Assets

6.03B

Forward PE Ratio

19.13

Breakdown by Asset Class

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	LLY	Eli Lilly and Company	9.05%	471,256
2	JNJ	Johnson & Johnson	7.48%	1,693,474
3	ABBV	AbbVie Inc.	4.63%	1,086,188
4	UNH	UnitedHealth Group Incorporated	4.33%	670,321
5	LON: AZN	AstraZeneca PLC	3.50%	1,299,386
6	TMO	Thermo Fisher Scientific Inc.	2.92%	284,886
7	NVSN.MX	Novartis AG ADR	2.78%	1,100,835
8	SWX: ROP	Roche Holding AG	2.63%	363,252
9	ARGX	argenx SE	2.55%	148,808
10	ABT	Abbott Laboratories	2.36%	1,286,064
11	MRK	Merck & Co., Inc.	2.29%	932,725
12	PRAX	Praxis Precision Medicines, Inc.	2.10%	360,852
13	BBIO	BridgeBio Pharma, Inc.	2.03%	1,599,850
14	RVMD	Revolution Medicines, Inc.	1.95%	570,336
15	CVS	CVS Health Corporation	1.95%	1,248,439
16	DHR	Danaher Corporation	1.93%	544,536
17	ISRG	Intuitive Surgical, Inc.	1.88%	300,436
18	VRTX	Vertex Pharmaceuticals Incorporated	1.80%	199,317
19	GILD	Gilead Sciences, Inc.	1.76%	724,620
20	AMGN	Amgen Inc.	1.70%	238,069
21	ASND	Ascendis Pharma A/S	1.61%	367,621
22	EPA: SAN	Sanofi	1.60%	1,080,583
23	SYK	Stryker Corporation	1.54%	286,415
24	TVTX	Travere Therapeutics, Inc.	1.53%	1,386,921
25	MDGL	Madrigal Pharmaceuticals, Inc.	1.38%	153,831

Showing 25 of 98 holdings

Subscribe to see the full list

Activate Now

As of Aug 31, 2026